NewsBenzingaCitigroup Initiates Coverage On Nuvation Bio with Buy Rating, Announces Price Target of $12 Citigroup Initiates Coverage On Nuvation Bio with Buy Rating, Announces Price Target of $12 Benzinga 2026.09.30 10:22 (GMT+0) Open on Benzinga Other news How to Play QCOM Stock as Apple Renews Licensing Agreement With Qualcomm Tinder adapts to a social, IRL dating future with ‘Group Hangouts’ feature What to Expect From Philip Morris International’s Next Quarterly Earnings Report What You Need to Know Ahead of Regions Financial's Earnings Release Dear Corteva Stock Fans, Mark Your Calendars for Oct. 1 KeyCorp’s Quarterly Earnings Preview: What You Need to Know
